stella
beta
Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients — Stella
Home
/
Glioblastoma (GBM)
/
View on ClinicalTrials.gov
Recruiting
Back to Glioblastoma (GBM) trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Zhongnan Hospital of Wuhan University, Wuhan, Hubei